Articles tagged with "juvenile idiopathic arthritis (JIA)"

European Medicines Agency Committee Issues Positive Opinion for Secukinumab in Pediatric Arthritic Disease

June 2, 2022 • By Michele B. Kaufman, PharmD, BCGP

This image from the MRI demonstrates suprapatellar bursal fluid of mixed signal.

Case Report: Persistent Knee Warmth Mimics Juvenile Idiopathic Arthritis

March 14, 2022 • By Eman Bamashmous, MBBS, Buthaina Al Adba, MBBS, CABP, & Sharon Bout-Tabaku, MD, MSCE

A Possible Diagnostic Tool: RheumMadness 2022 AI: JIA Subtypes Scouting Report

February 14, 2022 • By The Children’s Hospital at Montefiore Pediatric Rheumatology Fellowship Program: Alisha Akinsete, MD; Malki Peskin, MD; & Jessica Perfetto, MD

Tofacitinib Yields Rapid & Sustained Improvement in JIA

December 3, 2021 • By Reuters Staff

Management of Adults with JIA: Uveitis, MAS & More

December 2, 2021 • By Mary Beth Nierengarten

EU Approves Tofacitinib Citrate for 2 Pediatric Conditions

September 8, 2021 • By Michele B. Kaufman, PharmD, BCGP

Treatment Factors to Consider in Patients with JIA

July 18, 2021 • By Jason Liebowitz, MD

Manifestations of JIA: JIA-Associated Uveitis, sJIA & Lung Involvement in sJIA

July 16, 2021 • By Jason Liebowitz, MD

2 Pediatric Indications Sought for Golimumab

June 3, 2020 • By Michele B. Kaufman, PharmD, BCGP

Local Depletion of Resident Memory T Cells May Reduce Site-Specific Joint Flares

April 21, 2020 • By Carina Stanton